Clinical Trial Update: A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding saruparib to standard radiotherapy and androgen deprivation therapy improves metastasis-free survival in men with high…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Saruparib (saruparib)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING